Generic drugs are the rare part of American health care that actually drives down costs. In 2024, they accounted for 90 ...

Forbes contributors publish independent expert analyses and insights. The U.S. spent $722.5 billion on pharmaceuticals in 2023. Although brand-name drugs consume four out of every 5 dollars America ...

According to the American Medical Association, health related costs have been on the rise in recent years. Overall, health-related spending in the U.S. increased by over 7% between 2022 and 2023, a ...

This September marks 40 years since the birth of the generic drug industry in the United States. Nine out of every 10 prescriptions in the U.S. are filled by a generic drug. Generics — effectively ...

As drug prices continue to rise and the affordability of medicines for patients remains out of reach, finding new and creative solutions that address affordability, while also rewarding innovation, is ...

WASHINGTON, DC - APRIL 2: President Donald Trump signs an executive order imposing tariffs on imported goods during a "Make America Wealthy Again" trade announcement event in the Rose Garden at the ...

Cancer drugs among nearly 400 medicines at risk of shortage in UK - Exclusive: Drugs to treat stroke and schizophrenia patients could be hit if suppliers no longer see them as commercially viable ...

Though generic drugs represent more than 90% of dispensed prescriptions, generic drug manufacturers continue to face pressure from drug distributors, pharmacy benefit managers, and competitors. But ...

Investigation raises concerns about lack of FDA quality testing for generic drugs By some estimates, about 90% of prescriptions in the U.S. are filled with generic drugs. The Food and Drug ...

Buying generic medicines through websites becomes straightforward once you understand verification basics. Match the four critical details every time you order. Check deliveries thoroughly before ...

The post ProPublica Publishes Unreleased Data on the Origins of Generic Prescription Drugs appeared first on ProPublica.

British Columbians could soon have access to cheaper versions of injectable diabetes and obesity drugs.